Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerRodrigo Dienstmann, Josep Tabernero|Nature reviews. Cancer|2017Cited by 1k
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancerMalachi Griffith, Obi L. Griffith, Nicholas C. Spies et al.|Nature Genetics|2017Cited by 673
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationMarta Castroviejo‐Bermejo, Violeta Serra, Benedetta Pellegrino et al.|EMBO Molecular Medicine|2018Cited by 271
ESMO Guidance for Reporting Oncology real-World evidence (GROW)Luís Castelo-Branco, Miriam Koopman, Anna Pellat et al.|Annals of Oncology|2023Cited by 209
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancerElena Élez, Rodrigo A. Toledo, Javier Ros et al.|Nature Medicine|2022Cited by 111